The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon
PASSAGE DES LIONS 6, CASE POSTALE 5653, 1211 GENEVE 11, SWITZERLAND
Tel:
Work +41 22 319 22 00
Fax:
Fax +41 22 319 22 01
Email:
Web:
www.mangeat.ch

Fabien Aepli

Tel:
Work +41 22 319 22 00
Email:
Mangeat Attorneys at Law LLC

Work Department

Banking & Finance, Commercial Contracts and Corporate Law.

Fabien Aepli specialises in advising financial institutions (including banks, independent asset managers and distributors of collective investment schemes) on asset management matters and contracts, organisational rules, directives or processes, including when dealing with regulators (e.g. FINMA). He has proven experience in advising multinational companies and SMEs, on both Swiss and international level, in cross-border transactions such as agency, distribution, licence or service agreements.

He also specialises in drafting commercial contracts and general terms and conditions, and advising on compliance and regulatory issues. He advises companies and stakeholders on the structuring and setting-up of businesses and corporate reorganisation.

Position

Founder and Managing Partner at Mangeat Attorneys at Law LLC

Career

Since 2016 Partner at Mangeat Attorneys at Law LLC, Geneva

2011-2015 Partner at Eversheds Ltd, Geneva

2009 -2011 Senior associate at Eversheds Ltd, Geneva

2006 - 2009 Associate at a Swiss law firm, Geneva

2003 - 2005 Trainee at a Swiss law firm, Geneva

2000 - 2002 Part-time employee at an international industrial company, marketing finance     department, Lausanne

Languages

French, English, German

Member

• Geneva and Swiss Bar Associations
• British Swiss Chamber of Commerce
• Geneva Association of Corporate Law (AGDA)

Education

Certificate of Advanced Studies in Financial Regulation, Universities of Geneva and Bern (2017)

LL.M. in International Trade Law, University Institute Of European Studies, Turin, Italy (2015)

M.B.L.-HSG, Master of European and International Business Law, University Of St.Gallen (2007)

Program of Instruction for Lawyers, Harvard Law School, USA (Program on Negotiation, 2007)

Admitted to the Geneva Bar (2005)

Postgraduate degree, Institut de Lutte Contre la Criminalité Économique, Haute École ARC, Neuchâtel and Lausanne (2005)

Law degree (lic. iur.), Universities of Fribourg and Zurich (2003)


Switzerland

Banking and finance: Geneva

Within: Banking and finance: Geneva

With 'unique knowledge of corporate finance matters coupled with thorough understanding of business implications and technological development', Mangeat Attorneys at Law LLC focuses on asset management, anti-money laundering, finance transactions, as well as FINMA authorisations and rulings. Fabien Aepli, who 'masters banking and finance laws and can explain them in simple terms', and senior associate Nurith Cohen acted for Swiss Crypto Advisors on regulatory aspects, including anti-money laundering compliance, for its membership in a Swiss self-regulatory organisation.

[back to top]

Commercial, corporate and M&A

Within: Commercial, corporate and M&A

Mangeat Attorneys at Law LLC is recommended for having 'in-depth knowledge of commercial and corporate matters, combined with a thorough understanding of business implications and technological development'. M&A, corporate governance matters, reorganisations, compliance, commercial contracts and shareholder agreements form the bulk of its workload, while the banking, real estate and healthcare industries are sector strengths. The 'thorough and innovative' Fabien Aepli heads the practice, which also includes Joël Chevallaz and senior associate Nurith Cohen.

[back to top]

Healthcare and life sciences

Within: Healthcare and life sciences

'Seasoned in the complex licensing process prevalent in the healthcare sector', Mangeat Attorneys at Law LLC fields 'a solid team of lawyers', who stand out for their 'unique industry knowledge coupled with a thorough understanding of business implications and technological development'. For commercial contract and licence agreements, Fabien Aepli and 'exceptionally reactive, efficient and detail-oriented' senior associate Nurith Cohen are recommended, while senior associate Sara Dousset focuses on disciplinary, civil and criminal disputes involving healthcare and pharmaceutical clients.

[back to top]


Back to index

Legal Developments in Switzerland

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to
  • Ordinance on Integrity and Transparency in the Therapeutic Products Sector has been adopted

    Click here for more information.
  • Bär & Karrer Advises B3i in its Current Equity Funding Round

    Industry-led InsurTech B3i Services AG successfully raised additional funds from current shareholders and new investors to further develop and grow its blockchain-based insurance transaction platform. B3i was founded in October 2016 as an insurance industry consortium which then formed B3i Services AG as an independent company. The shareholder group includes some of the world's largest insurers and reinsurers from across Europe, the Americas, and Asia. B3i intends to further expand its shareholder base over the next several months.
  • Bär & Karrer Continues to Grow Finance and Sports Practice with Two New Partners

    Bär & Karrer is pleased to announce that it further strengthens its Financing and Sports practices with new partners Lukas Roesler and Dr. Jan Kleiner, both of whom have worked with the firm previously.
  • Bär & Karrer Advises Novartis and Alcon on the Spin-off of Alcon

    Today, Novartis AG completed the spin-off of the Alcon eye care devices business, and Alcon Inc. debuted as independent publicly traded company. The Alcon shares were successfully listed on the SIX Swiss Exchange Ltd. and the New York Stock Exchange. They are also included in the Swiss Market Index (SMI), which comprises the 20 largest Swiss listed stocks.
  • Bär & Karrer Advises Primeo Energie and CSA Energie-Infrastructure Schweiz in Aquisition from ElĂ©t

    Primeo Energie, EOS Holding SA (EOS) and Électricité de France (EDF) have entered into a share purchase agreement relating to the purchase by Primeo Energie and EOS of the 25% interest held by EDF in Alpiq Holding SA. The purchase by Primeo Eergie and EOS will be financed through mandatory exchangeable loan agreements made by CSA Energie-Infrastruktur Schweiz (CSA) as lender, the biggest investment pool for Swiss energy infrastructure with 135 Swiss pension funds acting as investors. At maturity the mandatory exchangeable loan agreements will be converted into shares in Alpiq. Primeo Energie and EOS thereby pave the way for a Swiss shareholder structure of Alpiq.
  • Bär & Karrer Awarded Most Innovative Swiss Law Firm of the Year at the IFLR Europe Awards

    Bär & Karrer was awarded „Most innovative law firm of the year - Switzerland", the national award for Switzerland given in the IFLR European Awards. The most innovative law firm of the year award recognizes Bär & Karrer as the Swiss law firm with the best track record in 2018 giving advice on the most innovative cross-border deals covering all award practice areas. It is already the third prize of this kind in period of six years awarded to Bär & Karrer.
  • Bär & Karrer Advises DSV on Public Exchange Offer for Panalpina

    On 1 April 2019, DSV A/S, Hedehusene, Denmark and Panalpina Welttransport (Holding) AG, Zurich, Switzerland, have entered into an agreement on the terms and conditions of a combination by way of a public exchange offer by DSV for all publicly held registered shares of Panalpina for approximately CHF 4.6 billion. The board of directors of Panalpina has resolved to support the public exchange offer by DSV and to recommend the acceptance of DSV's public exchange offer to its shareholders.
  • Bär & Karrer Advises Lonza on the Entering into a Strategic Joint Venture with Chr. Hansen for Deve

    On 2 April 2019, Lonza, a leading pharma contract manufacturing company, and Chr. Hansen, a leading global bioscience company, announced that they have signed an agreement to establish a 50/50 joint venture to pioneer the live biotherapeutic products (LBPs) industry and position themselves as the leading contract development and manufacturing partner (CDMO) for biotech and pharma customers. The joint venture brings together best-in-class, complementary capabilities and will be the first CDMO globally to provide a full supply chain that offers manufacturing of bacteria strains for therapeutic use. The joint venture will be a 50/50 controlled legal entity that will operate from its headquarters in Basel (CH) and have production facilities in Denmark and Switzerland. A phased investment of approximately EUR 90 million will be deployed over three years to build cGMP-compliant pharma production capabilities. The joint venture will upgrade existing facilities in Hørsholm (DK) and equip new facilities in Basel (CH) to serve pre-clinical to phase II projects. Further facilities for phase III and commercial manufacturing will be developed as the pipeline matures. The joint venture is expected to be largely self-funding after the production set-up has been established.
  • Bär & Karrer Advises Computacenter in the Acquisition of PathWorks

    Computacenter Group, a leading European IT service provider listed on the London Stock Exchange, acquired PathWorks, a well-established hardware reseller in the Swiss market.
  • Bär & Karrer Advises Addtech in the Acquisition of a Majority in Omni Ray

    Addtech Group, a leading Swedish publicly listed technology trading group, acquired a majority stake in Omni Ray AG, a well-established Swiss trading company and service provider for automation solutions, mainly focused on industrial applications, infrastructure, transportation and medical industry. By this transaction, Addtech aims at strengthening its position in the European automation market.